Skip to main content
Clinical Trials/EUCTR2011-001783-21-NL
EUCTR2011-001783-21-NLActive, not recruitingNot Applicable

Optimizing Pain Treatment in Pre-Term Neonates - Morphine study

Childrens's Research Institute0 sites60 target enrollmentStarted: December 29, 2011Last updated:
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional clinical trial of medicinal product

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Preterm neonates of both genders and all races
  • postnatal age less than 30 days
  • an indwelling (peripheral or umbilical) arterial line, and
  • a clinical indication for intravenous morphine administration
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 30
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

Exclusion Criteria

  • Neonates with severe asphyxia, grade III or IV intraventricular hemorrhage, major congenital malformations/facial malformations, neurological disorders, and those receiving continuous or intermittent neuromuscular blockers.
  • clinical or biochemical evidence of hepatic and renal compromise (including systemic hypoperfusion) or
  • received drugs that are UGT2B7 substrates (including Lorazepam, ibuprofen, valproic acid, naloxone and other morphine derivatives or propanolol)

Investigators

Sponsor
Childrens's Research Institute

Similar Trials

Optimizing Pain Treatment in Pre-Term... | Clinical Trial